428

Shares

Drug companies will be fined for overcharging 340B hospitals

Shared by Radhika Narayanan | 80 346 2 | about 2 years ago

The Obama administration has finalized a rule that imposes fines on drug companies that overcharge hospitals and clinics for medication purchased under the governments 340B drug discount programDrug companies must reimburse providers that overpaid for products and they are subject to fines of up to 5000 per instance if they overcharged knowingly and intentionallyThe penalties were outlined in a final rule released Wednesday by HHS Health Resources and Services Administration The rule also establishes a system for calculating ceiling prices for covered outpatient drugswhich some industry stakeholders say the agency lacks the authority to doThe proposed rule was initially released in 2015 with comments also due that year However HHS reopened the comment

Read More On www.modernhealthcare.com

Categories Digital chemistry & Pharma IT Hospital & Physicians

Links

http://www.modernhealthcare.com/article/20170104/NEWS/170109981
http://www.modernhealthcare.stfi.re/article/20170104/NEWS/170109981?sf=naezdrp
http://stfi.re/naezdrp
http://bit.ly/2hU0hXb

0 Votes

You must log in to post a comment

0 Comments